Association of metabolic syndrome in patients with vitiligo
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253743Keywords:
Cardiovascular disease, Metabolic syndrome, Type 2 diabetes, VitiligoAbstract
Background: Vitiligo can trigger inflammatory processes due to decreased number of melanocytes and their anti-inflammatory effects as well as oxidative stress. Metabolic syndrome includes hypertension, abdominal obesity, dyslipidemia, glucose intolerance, leading to cardiovascular disease, diabetes mellitus and stroke. Because of the systemic nature of vitiligo, metabolic syndrome or its component may be observed in vitiligo. To observe association of metabolic syndrome in patients with vitiligo.
Methods: This case control study included 54 vitiligo patients and 54 age and sex matched controls according to inclusion and exclusion criteria. Detailed history, physical examination and laboratory investigations were done in all participants and revised National Cholesterol Education Program Adult Treatment Panel III criteria were used for diagnosis of metabolic syndrome. Data were analyzed by using SPSS (Statistical Package for Social Sciences) Version 23.
Results: Metabolic syndrome was present in 20 (37.0%) patients with vitiligo and in 9 (16.7%) control subjects. Frequency of metabolic syndrome was significantly higher in vitiligo patient compared to control (p=0.017). Systolic blood pressure, diastolic blood pressure, fasting plasma glucose and mean serum triglycerides level were significantly higher in the patient group than that of control group, whereas serum high density lipoprotein cholesterol was significantly lower in the patient group than that of control group. There were no significant difference between cases and controls regarding waist circumference.
Conclusions: Presence of metabolic syndrome was higher in patients with vitiligo. Further large-scale studies are needed to establish it.
References
Marchioro HZ, Castro CCSD, Fava VM. Update on the pathogenesis of vitiligo. Anais Brasileiros de Dermatologia. 2022;97(4):478-90.
Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020;236(6):571-92.
Allam M, Riad H. Concise review of recent studies in vitiligo. Qatar Med J. 2014;2013(2):10.
Mohammed GF, Gomaa AH, Al-Dhubaibi MS. Highlights in pathogenesis of vitiligo. World J Clin Cases. 2015;3(3):221.
Adday NS, Ajlan SK, Al-Hamdi KI. Metabolic Syndrome and Vitiligo: The Relationship. University of Thi-Qar J Med. 2022;23(1):69-77.
Rochlani Y, Pothineni NV, Kovelamudi S. Metabolic syndrome: pathophysiology, management and modulation by natural compounds. Therap Advan Cardiovas Dis. 2017;11(8):215-25.
Sallam M, Gaballah MA, Al-Harrass M. Metabolic syndrome in Egyptian patients with vitiligo: a case–control study. J Egypt Women's Dermatol Soc. 2017;14(2):100-5.
Meymandi SS, Aflatoonian M, Khalili M. Prevalence of Metabolic Syndrome in Vitiligo Patients in Comparison With the Control Group. Hormozgan Med J. 2022;26(3):141-4.
Rani V, Deep G, Singh RK. Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sci. 2016;148:183-93.
Rashed EA, Fouda I, Elgmal E. Evaluation of the prevalence and risk of metabolic syndrome in vitiligo patients. Int J Med Arts. 2019;1(2):91-7.
Namazi N, Amani M, Haghighatkhah HR. Increased risk of subclinical atherosclerosis and metabolic syndrome in patients with vitiligo: a real association or a coincidence. Dermatol Ther. 2021;34(2):14803.
Gourh V, Arya A, Dubey A. Study of metabolic syndrome in patients of Vitiligo: A single-center observational study. Asian J Med Sci. 2022;13(9):168-73.
Sharma YK, Bansal P, Menon S. Metabolic syndrome in vitiligo patients among a semi-urban Maharashtrian population: a case control study. Diabet Met Syndr: Clin Res Rev. 2017;11(1):77-80.
Tanacan E, Atakan N. Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study. Anais Brasil Dermatol. 2020;95(2):165-72.
Aryanian Z, Shirzadian A, Farzaneh S. Metabolic derangement in patients with vitiligo: a cross-sectional study. J Invest Med. 2022;70(4):963-6.
Varma K, Kumar U, Mahadik A. ssociation of metabolic syndrome in patients of vitiligo. Indian J Clin Exp Dermatol. 2021;7(4):337-40.
Sinha PK, Nigam P, Swain JP. Association of metabolic syndrome with vitiligo. a case control study. J Evol Med Dental Sci. 2019;8(36):2783-7.
Hatice ATAS, Gönül, M. Increased risk of metabolic syndrome in patients with vitiligo. Balkan Med J. 2017:34(3):219-25.
Salman HA, Abdulkareem SR. Metabolic Syndrome in Iraqi Patients with Vitiligo. Am J Dermatol Venereol. 2020;9(3):43-6.
Downloads
Published
How to Cite
Issue
Section
